Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:CIPLA
Clear all filters
Bank of Baroda, Cipla, RIL, HDFC AMC Dividend Record Date: Last Day To Buy Shares To Qualify
positive
NDTV Profit 37d ago

Bank of Baroda, Cipla, RIL, HDFC AMC Dividend Record Date: Last Day To Buy Shares To Qualify

Dividend Record Date: Last Day To Buy Shares To Qualify

BANKBARODABANKINDIABBNPNBETFCIPLADIVIDENDHDFCBANKHDFCNIFBANHDFCPSUBKHDFCPVTBANFinancial ServicesHealthcare
Dividend, Bonus Issues This Week: RIL, Trent, Cipla, Ashok Leyland And More
positive
NDTV Profit 41d ago

Dividend, Bonus Issues This Week: RIL, Trent, Cipla, Ashok Leyland And More

Trent Ltd has fixed June 4 as the record date for a 1:2 bonus issue.

ASHOKLEYCIPLADIVIDENDTRENTCapital GoodsConsumer Services
Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focus - Upstox
positive
Google News - India Markets 41d ago

Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focus - Upstox

Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focusUpstox

ASHOKLEYCIPLADIVIDENDENERGYFOCUSGKENERGYJSWENERGYJSWHLJSWINFRAKPELTRENTWIPROCapital GoodsConstruction
Cipla Share Price Live Updates: Cipla's Market Activity
positive
ET Markets - Stocks 43d ago

Cipla Share Price Live Updates: Cipla's Market Activity

CIPLAHealthcare
Cipla to meet investors at Citi India Conference on June 5 - scanx.trade
neutral
Google News - India Markets 43d ago

Cipla to meet investors at Citi India Conference on June 5 - scanx.trade

Cipla to meet investors at Citi India Conference on June 5scanx.trade

CIPLAHealthcare
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta
positive
ET Markets - Industry 43d ago

Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant global product filings over the next three years. Cipla will also expand its presence in North America and Europe. Innovation is expected to contribute a meaningful portion of revenues in the coming decade.

CIPLAFOCUSGLOBALConsumer DurablesConsumer Services
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEO
positive
ET Markets - Industry 43d ago

Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEO

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to broaden its footprint in North America and Europe through sophisticated product offerings, Cipla is also intensifying its focus on managing chronic conditions such as diabetes and heart diseases in India.

CIPLAFOCUSConsumer DurablesHealthcare